These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16566872)

  • 1. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
    Mirza Y; O'Neill J; Smith EA; Russell A; Smith JM; Banerjee SP; Bhandari R; Boyd C; Rose M; Ivey J; Renshaw PF; Rosenberg DR
    J Child Neurol; 2006 Feb; 21(2):106-11. PubMed ID: 16566872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.
    Rosenberg DR; Amponsah A; Sullivan A; MacMillan S; Moore GJ
    J Child Neurol; 2001 Sep; 16(9):636-41. PubMed ID: 11575601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.
    Fitzgerald KD; Moore GJ; Paulson LA; Stewart CM; Rosenberg DR
    Biol Psychiatry; 2000 Feb; 47(3):174-82. PubMed ID: 10682215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
    Rosenberg DR; Mirza Y; Russell A; Tang J; Smith JM; Banerjee SP; Bhandari R; Rose M; Ivey J; Boyd C; Moore GJ
    J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1146-53. PubMed ID: 15322418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.
    Smith EA; Russell A; Lorch E; Banerjee SP; Rose M; Ivey J; Bhandari R; Moore GJ; Rosenberg DR
    Biol Psychiatry; 2003 Dec; 54(12):1399-405. PubMed ID: 14675804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
    Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
    J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.
    Szeszko PR; Christian C; Macmaster F; Lencz T; Mirza Y; Taormina SP; Easter P; Rose M; Michalopoulou GA; Rosenberg DR
    Am J Psychiatry; 2008 Oct; 165(10):1299-307. PubMed ID: 18413702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness.
    Fallucca E; MacMaster FP; Haddad J; Easter P; Dick R; May G; Stanley JA; Rix C; Rosenberg DR
    Arch Gen Psychiatry; 2011 May; 68(5):527-33. PubMed ID: 21536980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders.
    Mohamed MA; Smith MA; Schlund MW; Nestadt G; Barker PB; Hoehn-Saric R
    Psychiatry Res; 2007 Nov; 156(2):175-9. PubMed ID: 17904826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
    Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study.
    Mory SB; Li LM; Guerreiro CA; Cendes F
    Epilepsia; 2003 Nov; 44(11):1402-5. PubMed ID: 14636347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
    Wood SJ; Berger G; Velakoulis D; Phillips LJ; McGorry PD; Yung AR; Desmond P; Pantelis C
    Schizophr Bull; 2003; 29(4):831-43. PubMed ID: 14989417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An MRI and proton spectroscopy study of the thalamus in children with autism.
    Hardan AY; Minshew NJ; Melhem NM; Srihari S; Jo B; Bansal R; Keshavan MS; Stanley JA
    Psychiatry Res; 2008 Jul; 163(2):97-105. PubMed ID: 18508243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive functions in obsessive-compulsive disorder: An activation likelihood estimate meta-analysis of fMRI studies.
    Del Casale A; Rapinesi C; Kotzalidis GD; De Rossi P; Curto M; Janiri D; Criscuolo S; Alessi MC; Ferri VR; De Giorgi R; Sani G; Ferracuti S; Girardi P; Brugnoli R
    World J Biol Psychiatry; 2016 Aug; 17(5):378-93. PubMed ID: 26642972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy.
    Rosenberg DR; Benazon NR; Gilbert A; Sullivan A; Moore GJ
    Biol Psychiatry; 2000 Aug; 48(4):294-300. PubMed ID: 10960160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy.
    Kumar A; Thomas A; Lavretsky H; Yue K; Huda A; Curran J; Venkatraman T; Estanol L; Mintz J; Mega M; Toga A
    Am J Psychiatry; 2002 Apr; 159(4):630-6. PubMed ID: 11925302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural correlates of symptom dimensions in pediatric obsessive-compulsive disorder: a functional magnetic resonance imaging study.
    Gilbert AR; Akkal D; Almeida JRC; Mataix-Cols D; Kalas C; Devlin B; Birmaher B; Phillips ML
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):936-944. PubMed ID: 19625980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.